<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article"><?OLF?><?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName A++V2.4.dtd?><?SourceDTD.Version 2.4?><?ConverterInfo.XSLTName springer2nlmx2.xsl?><?ConverterInfo.Version 1?><?covid-19-tdm?><front><journal-meta><journal-id journal-id-type="nlm-ta">Sport Sci Health</journal-id><journal-id journal-id-type="iso-abbrev">Sport Sci Health</journal-id><journal-title-group><journal-title>Sport Sciences for Health</journal-title></journal-title-group><issn pub-type="ppub">1824-7490</issn><issn pub-type="epub">1825-1234</issn><publisher><publisher-name>Springer Milan</publisher-name><publisher-loc>Milan</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">8162633</article-id><article-id pub-id-type="publisher-id">787</article-id><article-id pub-id-type="doi">10.1007/s11332-021-00787-y</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Potential role of <italic>Nigella sativa</italic> supplementation with physical activity in prophylaxis and treatment of COVID-19: a contemporary review</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shirvani</surname><given-names>Hossein</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Rostamkhani</surname><given-names>Fatemeh</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2907-9798</contrib-id><name><surname>Arabzadeh</surname><given-names>Ehsan</given-names></name><address><email>eh.arabzadeh@bmsu.ac.ir</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mohammadi</surname><given-names>Faezeh</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Mohammadi</surname><given-names>Fatemeh</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.411521.2</institution-id><institution-id institution-id-type="ISNI">0000 0000 9975 294X</institution-id><institution>Exercise Physiology Research Center, Life Style Institute, </institution><institution>Baqiyatallah University of Medical Sciences, </institution></institution-wrap>Tehran, Iran </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.411463.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 0706 2472</institution-id><institution>Department of Biology, College of Basic Sciences, Yadegar-E-Imam Khomeini (RAH) Shahre Rey Branch, </institution><institution>Islamic Azad University, </institution></institution-wrap>Tehran, Iran </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.411705.6</institution-id><institution-id institution-id-type="ISNI">0000 0001 0166 0922</institution-id><institution>Maternal, Fetal&#x00026; Neonatal Research Center, </institution><institution>Tehran University of Medical Sciences (TUMS), </institution></institution-wrap>Tehran, Iran </aff></contrib-group><pub-date pub-type="epub"><day>28</day><month>5</month><year>2021</year></pub-date><fpage>1</fpage><lpage>6</lpage><history><date date-type="received"><day>9</day><month>2</month><year>2021</year></date><date date-type="accepted"><day>18</day><month>5</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s), under exclusive licence to Springer-Verlag Italia S.r.l., part of Springer Nature 2021</copyright-statement><license><license-p>This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">The widespread prevalence and mortality of coronavirus diseases-2019 (COVID-19) lead many researchers to study the SARS-CoV-s2 infection to find a treatment for this disease. Discovering the mechanisms of action of COVID-19 and coping at the cellular level with this disease can have better effects. Including the target tissues of this disease are the lungs and the immune system. It is stated that COVID-19 easily infiltrates into alveoli through its receptors and then starts to proliferate. Subsequently, with the weakening of immune cells and increase inflammatory cytokines, it increases the rate of inflammation in the body. Strengthening the immune system and inhibiting COVID-19 receptors can play a preventive or even therapeutic role for this disease. <italic>Nigella sativa</italic> (<italic>N. sativa</italic>) is one of the herbal medicines to possess numerous pharmacological effects related to several organs of the body. Among the extraordinary properties of this plant is improving asthma and several lung diseases. The recent studies have shown that <italic>N. sativa</italic> at the cellular level can inhibit COVID-19 receptors. It was also stated that performing regular exercise training (especially moderate-intensity exercise training) can modulate the immune system and have an anti-inflammatory effect. Since the use of herbal supplements with exercise can have tremendous therapeutic effects at the cellular level, the hypothesis to use the <italic>Nigella sativa</italic> along with exercise training to prophylaxis and treatment COVID-19 will be highlighted in this paper.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>COVID-19</kwd><kwd><italic>Nigella sativa</italic> supplementation</kwd><kwd>Physical activity</kwd><kwd>Exercise</kwd><kwd>Treatment</kwd><kwd>Prevention</kwd></kwd-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">COVID-19 has been recognized as pandemic by the world health organization (WHO) since March 11, 2020 [<xref ref-type="bibr" rid="CR1">1</xref>]. It has been shown that COVID-19 causes wide mortality and has also irreparable economic damage to countries around the world. COVID-19 initially affects the cells of the small air sacs known as the alveoli. Alveoli are made up of alveolar cells (also known as pneumocytes) and alveolar macrophages. COVID-19 causes inflammation in the lung tissue, which is usually accompanied by symptoms such as dry cough, chest pain, fever, and difficulty breathing [<xref ref-type="bibr" rid="CR2">2</xref>]. These symptoms gradually worsen and cause death in people with COVID-19 [<xref ref-type="bibr" rid="CR3">3</xref>].</p><p id="Par3">Simultaneously with the involvement of lung tissue, the immune system usually reacts to fight the virus. It is stated that in COVID-19, changes in patients' immune systems are more similar. Usually, after COVID-19, a decrease in the number of CD4+&#x02009;and CD8+&#x02009;lymphocytes, monocytes and platelets has been recorded with an increase in the number of neutrophils [<xref ref-type="bibr" rid="CR4">4</xref>]. Elevated concentrations of CRP, interleukin-6 (IL-6), serum ferritin, and erythrocyte sedimentation rate (ESR) have been reported in COVID-19 patients [<xref ref-type="bibr" rid="CR5">5</xref>]. In addition to these factors, an excessive increase in some cytokines, such as IL-7, IL-10, GCSF, IP10, MCP1, MIP1A, and TNF-&#x003b1; has been observed [<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR7">7</xref>]. In contrast, an increase in lymphocyte levels was observed in the review of the improved immune system [<xref ref-type="bibr" rid="CR5">5</xref>]. Therefore, strengthening and improving the function of lung cells, strengthening the immune system, and controlling pro-inflammatory cytokines can be suitable for the prevention or even treatment of COVID-19. There are lots of research that has been done on COVID-19, and they have proposed various treatment strategies. Meanwhile, exercise physiology scientists, especially molecular and cellular exercise physiologists, also use various exercise intensities as a preventive method for COVID-19 due to the positive effects of exercise training on the immune system [<xref ref-type="bibr" rid="CR8">8</xref>&#x02013;<xref ref-type="bibr" rid="CR10">10</xref>].</p><p id="Par4">Because the use of herbal supplements improves the effects of regular exercise training (reducing ROS), it seems that the combination of exercise training and herbal supplement can counteract COVID-19 or even reduce destructive effects of COVID-19 [<xref ref-type="bibr" rid="CR11">11</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>]. <italic>Nigella sativa</italic> (<italic>N. sativa</italic>) is one of the useful herbal medicines that have a strong positive effect on the lungs and also improve the immune system. Therefore, in this study, the hypothesis considers the potential role of <italic>N. sativa</italic> supplementation with physical activity in the prophylaxis and treatment of COVID-19.</p></sec><sec id="Sec2"><title>Effectiveness of <italic>Nigella sativa</italic> on lung tissue, immune system, and COVID-19</title><p id="Par5"><italic>Nigella sativa</italic>, known as black cumin belongs to the Ranunculaceae family. <italic>N. sativa</italic> has been used all over the world in cooking and for its many medicinal properties. Various studies have confirmed the beneficial effects of <italic>N. sativa</italic> on the respiratory system, lung parenchyma, narrowing of the airways, stimulating the body's energy, and improving fatigue, as well as its anti-inflammatory effects [<xref ref-type="bibr" rid="CR14">14</xref>&#x02013;<xref ref-type="bibr" rid="CR16">16</xref>]. The seeds of this plant are very useful and have different chemical compositions and also contain amino acids, proteins, carbohydrates, and volatile oil (0.5 to maximum 1.5%), and fixed oil (30%). Many of the medicinal properties of <italic>N. sativa</italic> are due to the quinone compounds in its seed [<xref ref-type="bibr" rid="CR17">17</xref>]. The composition of this plant includes four types of alkaloids called Nigellamine (1) A, (2) A, (1) B, (2) B, which is extracted from the seed of this plant. Thymoquinone (TQ), Dithymoquinone (TQ2), Thymohydroquinone (THQ), and Thymol are the main active ingredients in the aqueous extract of the <italic>N. sativa</italic> [<xref ref-type="bibr" rid="CR18">18</xref>] (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1"><label>Fig. 1</label><caption><p>Chemical structure of Thymol (<bold>a</bold>), Thymoquinone (<bold>b</bold>), and Dithymoquinone (<bold>c</bold>)</p></caption><graphic xlink:href="11332_2021_787_Fig1_HTML" id="MO1"/></fig></p><p id="Par6"><italic>Nigella sativa</italic> is useful for improving and treatment of respiratory disorders, such as asthma and bronchial spasm [<xref ref-type="bibr" rid="CR19">19</xref>]. Nigellon is an <italic>N. sativa</italic> compound (a polymer in TQ or TQ2) that can relieve airway obstruction. In fact, Nigellone blocks the release of histamine, which causes narrowing of the airways [<xref ref-type="bibr" rid="CR19">19</xref>]. Numerous studies have also investigated the anti-inflammatory [<xref ref-type="bibr" rid="CR14">14</xref>] and anti-asthmatic [<xref ref-type="bibr" rid="CR20">20</xref>] effects of <italic>N. sativa</italic> in lung tissue. Therefore, <italic>N. sativa</italic> can have therapeutic effects in most lung diseases [<xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par7">Regarding the effect of <italic>N. sativa</italic> on the immune system, it has been shown that the distribution of <italic>N. sativa</italic> effects on pro-and anti-inflammatory cytokines (increasing anti-inflammatory cytokines and decreasing pro-inflammatory cytokines). Also, <italic>N. sativa</italic> can modulate Th1/Th2 lymphocytes function [<xref ref-type="bibr" rid="CR22">22</xref>]. Khabbazi et al. showed the immunomodulatory effects of <italic>N. sativa</italic> on T lymphocytes in chronic disease and stated that treatment with <italic>N. sativa</italic> improves rheumatoid arthritis through its immunomodulatory effects on T cells [<xref ref-type="bibr" rid="CR23">23</xref>]. It is stated that <italic>N. sativa</italic> is able to activate T lymphocytes and have an immunomodulatory effect in human subjects [<xref ref-type="bibr" rid="CR24">24</xref>]. Oral gavage of <italic>N. sativa</italic> in diabetic animals, increases lymphocyte content in the peripheral bloodstream [<xref ref-type="bibr" rid="CR25">25</xref>]. Owing to the beneficial effects of <italic>N. sativa</italic> on the lung tissue and immune system, it seems <italic>N. sativa</italic> may also play a treatment role in COVID-19.</p><p id="Par8">It has been shown that TQ has the ability to block ACE2 (a COVID-19 receptor) [<xref ref-type="bibr" rid="CR26">26</xref>]. In other words, TQ may block the entry of COVID-19 into pneumocytes. Therefore, both nigellimine and thymoquinone from <italic>N. sativa</italic> may be considered as potentially active pharmacological components for the treatment of COVID-19. Recently, Rahman showed that <italic>N. sativa</italic>, with a wide range of bioactive components, such as nigellimine and thymoquinone, may have many benefits in the treatment of COVID-19, including prevention of the virus enters the pneumocyte and prepares an ionophore for an enhanced uptake of Zn<sup>2+</sup>, which can increase the host's immune response to COVID-19 and also prevent viral replication by blocking viral RdRp. This researcher suggested a dose of black seed oil between 40 and 80&#x000a0;mg/kg per day as adjunctive therapy without any side effects [<xref ref-type="bibr" rid="CR26">26</xref>]. Ulasli et al. showed that <italic>N. sativa</italic> reduces the coronavirus load in infected HeLa cells by stimulating IL-8 secretion and downregulation of expression of transient receptor potential (TRP) genes, such as TRPM6, TRPA1, TRPC4, and TRPM7 [<xref ref-type="bibr" rid="CR27">27</xref>]. Also, it has been shown that N. sativa components or antiviral drugs can limit COVID-19 targets, such as main proteases (6LU7 and 6Y2E), main peptidase (2GTB), angiotensin-converting enzyme 2 (ACE2), and heat shock protein A5 [<xref ref-type="bibr" rid="CR28">28</xref>].</p><p id="Par9">Some natural compounds may prevent the coronavirus from adhering to the host epithelial cell. It has been shown that Nigelledine, an <italic>N. sativa</italic> alkaloid, can block 6LU7, and &#x003b1;-Hederin, a saponin of <italic>N. sativa</italic>, can block 2GTB [<xref ref-type="bibr" rid="CR28">28</xref>]. As stated TQ is also one of the essential oils of <italic>N. sativa</italic> that tends to bind to 6LU7, ACE2, and heat shock protein A5 active sites [<xref ref-type="bibr" rid="CR29">29</xref>]. Also, Hederagenin (a saponin in <italic>N. sativa</italic>) binds with 6LU7, 6Y2E, ACE2, and active sites of GRP78 [<xref ref-type="bibr" rid="CR30">30</xref>]. Thymohydroquinone showed moderate binding energy to SARS-CoV-2 6LU7, endoribonuclease, ADP-ribose-1-phosphatase, RNA-dependent RNA polymerase, SARS-CoV-2 protein-binding domain [<xref ref-type="bibr" rid="CR31">31</xref>]. Nigellidine also showed high binding to COVID-19 enzymes and proteins, such as N-terminus-proteinase, 6LU7, nonstructural protein 2, spike-glycoprotein, and nucleocapsid. Nigellidine has a high affinity for inflammatory signal molecules and other proteins, such as human IL1R (1itb), TNFR1 (1ncf), and TNFR2 (3alq) [<xref ref-type="bibr" rid="CR32">32</xref>]. According to this research, some components of <italic>N. sativa</italic> provide the ability to inhibit the entry of coronavirus into lung cells and immunity, including nigellidine, &#x003b1;-hederin, hederagenin, thymohydroquinone, and thymoquinone.</p></sec><sec id="Sec3"><title>Effectiveness of physical activity on lung tissue, immune system, and COVID-19</title><p id="Par10">In the recent decades, exercise and physical activity have been considered appropriate treatment options for respiratory and lung diseases [<xref ref-type="bibr" rid="CR33">33</xref>]. Exercise can increase functional capacity, increase exercise tolerance, and improve the health-related quality of life (HRQoL) in lung disease [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Fatigue is one of the most common symptoms in patients with respiratory disorders [<xref ref-type="bibr" rid="CR35">35</xref>]. Keyser et al. showed that aerobic exercise reduces the rate of fatigue in interstitial pulmonary disease (ILD) [<xref ref-type="bibr" rid="CR36">36</xref>]. Decreased fatigue was associated with an improvement in the patient's perception of fatigue and increased exercise capacity [<xref ref-type="bibr" rid="CR36">36</xref>]. Casaburi et al. also showed that in obstructive pulmonary disease, aerobic exercise (8-week, 90% aerobic threshold on cycle ergometer) reduces lactate acidosis and improves ventilation [<xref ref-type="bibr" rid="CR37">37</xref>]. It has been shown that low and moderate intensity aerobic exercise (50 and 75% of maximal speed) reduces airway inflammation and improves lung remodeling in asthmatic mice [<xref ref-type="bibr" rid="CR38">38</xref>]. Aerobic exercise also reduces parenchymal artery inflammation. These effects of exercise on lung tissue may be due to a decrease in the Th2 response, an increase in interleukin-10, and a decrease in the expression of NF-KB, MCP-1, and IGF-I [<xref ref-type="bibr" rid="CR39">39</xref>]. It has been suggested that part of the effects of exercise on the immune system is due to the ability of exercise to modulate the cellular metabolism of lymphocytes, especially glucose and glutamine. It was observed that the change in lymphocyte function is associated with different effects of moderate exercise intensity (40&#x02013;60% <italic>V</italic>O<sub>2max</sub>) on T and B lymphocyte metabolism [<xref ref-type="bibr" rid="CR40">40</xref>]. In particular, T lymphocytes increase glutamine intake by altering the metabolism of this amino acid to the aerobic pathway. At the same time, these cells reduce glucose intake and lactate production levels. In contrast, B lymphocytes showed that it increases the consumption of both glucose and glutamine [<xref ref-type="bibr" rid="CR40">40</xref>]. All of these changes in lymphocytes can provide a stronger defense of lymphocytes against viruses. Owing to the wide cellular effects of exercise training on lung tissue, immune system, and viral diseases, it seems that it could be used to prevent viral diseases, especially COVID-19. Few studies have examined the preventive and even therapeutic effects of exercise on COVID-19.</p><p id="Par11">As mentioned, one of the recognizable features in COVID-19 disease is cytokine storm which includes increase: IL-6, IL-1B, IL-2, IL-8, IL-17, G-CSF, GM-CSF, IFN-&#x003b3;, IP10, MCP1, MIP1a, and TNF-&#x003b1;, and is known as an acute systemic inflammatory syndrome [<xref ref-type="bibr" rid="CR41">41</xref>], which can induce oxidative stress, which is detrimental to cells. Among the effects of exercise training, especially aerobic exercise training (40&#x000a0;min each session, 3 times per week for 6&#x000a0;months; first 3&#x000a0;months&#x02009;=&#x02009;60&#x02013;70% of HRmax, second 3&#x000a0;months&#x02009;=&#x02009;70&#x02013;80% of HRma) is the strengthening of anti-inflammatory cytokines and the improvement of oxidative stress in elderly [<xref ref-type="bibr" rid="CR42">42</xref>]. Falkenberg et al. in a systematic review study examined the effect of yoga mental exercise on immune function. Their results showed that yoga reduced levels of TNF-&#x003b1;, IL-6, IL-1&#x003b2; as well as improved cellular and mucosal immunity in people who were suffering from inflammatory diseases [<xref ref-type="bibr" rid="CR43">43</xref>]. An acute exercise session (moderate intensity less than 1&#x000a0;h) has been shown to activate immune system cells in the bloodstream and various tissues (such as mucosal surfaces including respiratory and gut epithelial), which strengthens the innate immune system [<xref ref-type="bibr" rid="CR44">44</xref>]. Regular aerobic exercise (moderate intensity) also increases the antipathogenic activity of macrophages, which is associated with increased blood flow immunoglobulins, neutrophils, anti-inflammatory cytokines, immature B cells, the dramatic influx of natural killer cells (NK), and CD8&#x02009;+&#x02009;T cells [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. Also, acute and chronic moderate-intensity exercise regulates excessive inflammation in the airways [<xref ref-type="bibr" rid="CR47">47</xref>]. Chronic exercise (over a 6-month period) prevents age-related immune dysfunction (chronic inflammation) and improves the effectiveness of influenza vaccination in the elderly without harmful side effects [<xref ref-type="bibr" rid="CR48">48</xref>]. The effect of moderate exercise (chronic, 40&#x02013;60% <italic>V</italic>O<sub>2max</sub>) on immune function is especially beneficial for the elderly because they are vulnerable to COVID-19. There is evidence that regular physical activity and an active lifestyle are beneficial for immune function [<xref ref-type="bibr" rid="CR49">49</xref>]. Exercise training has been known as a lifestyle factor that can maintain and even promote immune function and act like a vaccine against certain diseases/infections through producing physiological stress in the human body which lead to a series of adaptations occurring to overcome these stimuli [<xref ref-type="bibr" rid="CR50">50</xref>].</p><p id="Par12">Based on the clinical studies in humans, performing short-term exercise (e.g. 45&#x02013;60&#x000a0;min), and moderate exercise (40&#x02013;60% <italic>V</italic>O<sub>2max</sub>), at least 3 times per week is useful for the immune system [<xref ref-type="bibr" rid="CR51">51</xref>]. Moderate-intensity exercise is also associated with increased leukocyte function in humans [<xref ref-type="bibr" rid="CR52">52</xref>]. Exercise increases chemotaxis, degranulation, cytotoxic activity, phagocytosis, and oxidative activity of neutrophils and macrophages in rats [<xref ref-type="bibr" rid="CR53">53</xref>]. Increased cytolytic activity of NK cells and activating lymphokine-activated killer cells (LAK) during 60&#x000a0;min of moderate-intensity exercise has also been reported by healthy cyclists [<xref ref-type="bibr" rid="CR54">54</xref>]. Various studies have shown that regular exercise (resistance or endurance training) increases macrophage phagocytosis, oxidative burst, neutrophil oxidative burst, percentage of TCD4 lymphocytes, and reduces circulating TNF-&#x003b1; and IL-6 [<xref ref-type="bibr" rid="CR51">51</xref>]. Therefore, exercise training with positive effects on the immune system can play a therapeutic and preventive effect against COVID-19.</p></sec><sec id="Sec4"><title>Potential role of <italic>Nigella sativa</italic> supplementation with physical activity against COVID-19</title><p id="Par13">Lung tissue is one of the most important issues that are responsible for providing oxygen for oxidative phosphorylation during daily physical activity and exercise training. Exercise training and regular physical activity can strengthen the alveoli as well as the immune system associated with improving lung cells and ultimately functional capacity [<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR56">56</xref>]. On the other hand, in traditional medicine, special attention has been given to the use of <italic>N. sativa</italic> in the treatment of pulmonary diseases. Most of these studies have given attention to the medicinal properties of this plant on the respiratory system [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR57">57</xref>]. However, no study has been performed on the use of <italic>N. sativa</italic> along with exercise training on COVID-19. Many common mechanisms of exercise training and <italic>N. sativa</italic> can affect COVID-19. It seems that consumption of black seed (black seed oil dose 40&#x02013;80&#x000a0;mg/kg/day) along with regular aerobic exercise (40&#x02013;60% <italic>V</italic>O<sub>2max</sub>) could strengthen the immune system by increasing lymphocyte activity and metabolism, reducing cytokine storms, increasing anti-inflammatory cytokines, and inhibiting COVID-19 receptors (by various active components of <italic>N. sativa</italic> including TQ), which may play a prophylaxis and treatment role for COVID-19.</p></sec><sec id="Sec5"><title>Conclusion</title><p id="Par14">The recent studies have shown that <italic>N. sativa</italic> can play a therapeutic role for COVID-19 by strengthening the immune and respiratory systems as well as inhibiting Covid-19 receptors. On the other hand, exercise training can have anti-inflammatory effects and improve immunity. Also, studies show that low to moderate intensity exercise training is useful for some respiratory diseases. Based on the previous research, it seems that a lifestyle combined with exercise training and <italic>N. sativa</italic> supplementation can be effective in reducing COVID-19 mortality.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes notes-type="funding-information"><title>Funding</title><p>None. The authors do not have any personal or institutional financial interests in drugs, materials, or devices described in this paper.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Conflict of interest</title><p id="Par15">The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</p></notes><notes><title>Informed consent</title><p>Not applicable.</p></notes><notes><title>Ethical approval</title><p>This article does not contain any studies with human participants performed by any of the authors.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cucinotta</surname><given-names>D</given-names></name><name><surname>Vanelli</surname><given-names>M</given-names></name></person-group><article-title>WHO declares COVID-19 a pandemic</article-title><source>Acta Bio Medica Atenei Parmensis</source><year>2020</year><volume>91</volume><issue>1</issue><fpage>157</fpage><?supplied-pmid 32191675?><pub-id pub-id-type="pmid">32191675</pub-id></element-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="other">Huang C, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B et al (2020) Lancet 395(10223):497&#x02013;506</mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="other">Mallapaty S (2020) Scientists fear coronavirus spread in vulnerable nations. Nature 578(7795):348&#x02013;348 &#x000a0;</mixed-citation></ref><ref id="CR4"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Coronavirus disease 2019 in elderly patients: characteristics and prognostic factors based on 4-week follow-up</article-title><source>J Infect</source><year>2020</year><volume>80</volume><fpage>639</fpage><lpage>645</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2020.03.019</pub-id><?supplied-pmid 32240670?><pub-id pub-id-type="pmid">32240670</pub-id></element-citation></ref><ref id="CR5"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N</given-names></name><etal/></person-group><article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study</article-title><source>Lancet Lond Engl</source><year>2020</year><volume>395</volume><fpage>507</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30211-7</pub-id></element-citation></ref><ref id="CR6"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lescure</surname><given-names>F-X</given-names></name><etal/></person-group><article-title>Clinical and virological data of the first cases of COVID-19 in Europe: a case series</article-title><source>Lancet Infect Dis</source><year>2020</year><volume>20</volume><fpage>697</fpage><lpage>706</lpage><pub-id pub-id-type="doi">10.1016/S1473-3099(20)30200-0</pub-id><?supplied-pmid 32224310?><pub-id pub-id-type="pmid">32224310</pub-id></element-citation></ref><ref id="CR7"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Clinical features of 69 cases with coronavirus disease 2019 in Wuhan, China</article-title><source>Clin Infect Dis</source><year>2020</year><volume>37</volume><fpage>420</fpage><lpage>430</lpage></element-citation></ref><ref id="CR8"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scudiero</surname><given-names>O</given-names></name><etal/></person-group><article-title>Exercise, immune system, nutrition, respiratory and cardiovascular diseases during COVID-19: a complex combination</article-title><source>Int J Environ Res Public Health</source><year>2021</year><volume>18</volume><issue>3</issue><fpage>904</fpage><pub-id pub-id-type="doi">10.3390/ijerph18030904</pub-id><?supplied-pmid 33494244?><pub-id pub-id-type="pmid">33494244</pub-id></element-citation></ref><ref id="CR9"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silveira</surname><given-names>MP</given-names></name><etal/></person-group><article-title>Physical exercise as a tool to help the immune system against COVID-19: an integrative review of the current literature</article-title><source>Clin Exp Med</source><year>2020</year><volume>21</volume><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">32712721</pub-id></element-citation></ref><ref id="CR10"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scartoni</surname><given-names>FR</given-names></name><etal/></person-group><article-title>Physical exercise and immune system in the elderly: implications and importance in COVID-19 pandemic period</article-title><source>Front Psychol</source><year>2020</year><volume>11</volume><fpage>3215</fpage><pub-id pub-id-type="doi">10.3389/fpsyg.2020.593903</pub-id></element-citation></ref><ref id="CR11"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sellami</surname><given-names>M</given-names></name><etal/></person-group><article-title>Herbal medicine for sports: a review</article-title><source>J Int Soc Sports Nutr</source><year>2018</year><volume>15</volume><issue>1</issue><fpage>1</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1186/s12970-018-0218-y</pub-id><pub-id pub-id-type="pmid">29311763</pub-id></element-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="other">Molanouri SM, Amani SS (2020) Exercise training, immune system, and coronavirus. Res Sport Sci 12(46):17&#x02013;40</mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="other">Chakraborty S et al (2020) COVID-19 pandemic: pharmacological uses of plants to boost immune system. Res J Med Health Sci 1(1):17&#x02013;21</mixed-citation></ref><ref id="CR14"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boskabady</surname><given-names>MH</given-names></name><etal/></person-group><article-title>The effect of <italic>Nigella sativa</italic> alone, and in combination with dexamethasone, on tracheal muscle responsiveness and lung inflammation in sulfur mustard exposed guinea pigs</article-title><source>J Ethnopharmacol</source><year>2011</year><volume>137</volume><issue>2</issue><fpage>1028</fpage><lpage>1034</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2011.07.030</pub-id><?supplied-pmid 21801826?><pub-id pub-id-type="pmid">21801826</pub-id></element-citation></ref><ref id="CR15"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gholamnezhad</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Clinical and experimental effects of <italic>Nigella sativa</italic> and its constituents on respiratory and allergic disorders</article-title><source>Avicenna J Phytomed</source><year>2019</year><volume>9</volume><issue>3</issue><fpage>195</fpage><?supplied-pmid 31143688?><pub-id pub-id-type="pmid">31143688</pub-id></element-citation></ref><ref id="CR16"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mokhtari-Zaer</surname><given-names>A</given-names></name><etal/></person-group><article-title>The protective effect of <italic>Nigella sativa</italic> extract on lung inflammation and oxidative stress induced by lipopolysaccharide in rats</article-title><source>J Ethnopharmacol</source><year>2020</year><volume>253</volume><fpage>112653</fpage><pub-id pub-id-type="doi">10.1016/j.jep.2020.112653</pub-id><?supplied-pmid 32035219?><pub-id pub-id-type="pmid">32035219</pub-id></element-citation></ref><ref id="CR17"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gali-Muhtasib</surname><given-names>H</given-names></name><name><surname>El-Najjar</surname><given-names>N</given-names></name><name><surname>Schneider-Stock</surname><given-names>R</given-names></name></person-group><article-title>The medicinal potential of black seed (<italic>Nigella sativa</italic>) and its components</article-title><source>Adv Phytomed</source><year>2006</year><volume>2</volume><fpage>133</fpage><lpage>153</lpage><pub-id pub-id-type="doi">10.1016/S1572-557X(05)02008-8</pub-id></element-citation></ref><ref id="CR18"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Venkatachallam</surname><given-names>SKT</given-names></name><etal/></person-group><article-title>Chemical composition of <italic>Nigella sativa</italic> L. seed extracts obtained by supercritical carbon dioxide</article-title><source>J Food Sci Technol</source><year>2010</year><volume>47</volume><issue>6</issue><fpage>598</fpage><lpage>605</lpage><pub-id pub-id-type="doi">10.1007/s13197-010-0109-y</pub-id><pub-id pub-id-type="pmid">23572692</pub-id></element-citation></ref><ref id="CR19"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilani</surname><given-names>A-UH</given-names></name><name><surname>Jabeen</surname><given-names>Q</given-names></name><name><surname>Khan</surname><given-names>MAU</given-names></name></person-group><article-title>A review of medicinal uses and pharmacological activities of <italic>Nigella sativa</italic></article-title><source>Pak J Biol Sci</source><year>2004</year><volume>7</volume><issue>4</issue><fpage>441</fpage><lpage>451</lpage><pub-id pub-id-type="doi">10.3923/pjbs.2004.441.451</pub-id></element-citation></ref><ref id="CR20"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khan</surname><given-names>MA</given-names></name></person-group><article-title>Chemical composition and medicinal properties of <italic>Nigella sativa</italic> Linn.</article-title><source>Inflammopharmacology</source><year>1999</year><volume>7</volume><issue>1</issue><fpage>15</fpage><lpage>35</lpage><pub-id pub-id-type="doi">10.1007/s10787-999-0023-y</pub-id><?supplied-pmid 17657444?><pub-id pub-id-type="pmid">17657444</pub-id></element-citation></ref><ref id="CR21"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kanter</surname><given-names>M</given-names></name></person-group><article-title>Effects of <italic>Nigella sativa</italic> seed extract on ameliorating lung tissue damage in rats after experimental pulmonary aspirations</article-title><source>Acta Histochem</source><year>2009</year><volume>111</volume><issue>5</issue><fpage>393</fpage><lpage>403</lpage><pub-id pub-id-type="doi">10.1016/j.acthis.2008.10.008</pub-id><?supplied-pmid 19428057?><pub-id pub-id-type="pmid">19428057</pub-id></element-citation></ref><ref id="CR22"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Majdalawieh</surname><given-names>AF</given-names></name><name><surname>Hmaidan</surname><given-names>R</given-names></name><name><surname>Carr</surname><given-names>RI</given-names></name></person-group><article-title><italic>Nigella sativa</italic> modulates splenocyte proliferation, Th1/Th2 cytokine profile, macrophage function and NK anti-tumor activity</article-title><source>J Ethnopharmacol</source><year>2010</year><volume>131</volume><issue>2</issue><fpage>268</fpage><lpage>275</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2010.06.030</pub-id><?supplied-pmid 20600757?><pub-id pub-id-type="pmid">20600757</pub-id></element-citation></ref><ref id="CR23"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Khabbazi</surname><given-names>A</given-names></name><etal/></person-group><article-title>A systematic review of the potential effects of <italic>Nigella sativa</italic> on rheumatoid arthritis</article-title><source>Planta Med</source><year>2020</year><volume>86</volume><issue>07</issue><fpage>457</fpage><lpage>469</lpage><pub-id pub-id-type="doi">10.1055/a-1143-8521</pub-id><?supplied-pmid 32274788?><pub-id pub-id-type="pmid">32274788</pub-id></element-citation></ref><ref id="CR24"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kheirouri</surname><given-names>S</given-names></name><name><surname>Hadi</surname><given-names>V</given-names></name><name><surname>Alizadeh</surname><given-names>M</given-names></name></person-group><article-title>Immunomodulatory effect of <italic>Nigella sativa</italic> oil on T lymphocytes in patients with rheumatoid arthritis</article-title><source>Immunol Invest</source><year>2016</year><volume>45</volume><issue>4</issue><fpage>271</fpage><lpage>283</lpage><pub-id pub-id-type="doi">10.3109/08820139.2016.1153649</pub-id><?supplied-pmid 27100726?><pub-id pub-id-type="pmid">27100726</pub-id></element-citation></ref><ref id="CR25"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fararh</surname><given-names>K</given-names></name><etal/></person-group><article-title>Mechanisms of the hypoglycaemic and immunopotentiating effects of <italic>Nigella sativa</italic> L. oil in streptozotocin-induced diabetic hamsters</article-title><source>Res Vet Sci</source><year>2004</year><volume>77</volume><issue>2</issue><fpage>123</fpage><lpage>129</lpage><pub-id pub-id-type="doi">10.1016/j.rvsc.2004.03.002</pub-id><?supplied-pmid 15196902?><pub-id pub-id-type="pmid">15196902</pub-id></element-citation></ref><ref id="CR26"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rahman</surname><given-names>MT</given-names></name></person-group><article-title>Potential benefits of combination of <italic>Nigella sativa</italic> and Zn supplements to treat COVID-19</article-title><source>J Herb Med</source><year>2020</year><volume>23</volume><fpage>100382</fpage><pub-id pub-id-type="doi">10.1016/j.hermed.2020.100382</pub-id><?supplied-pmid 32834942?><pub-id pub-id-type="pmid">32834942</pub-id></element-citation></ref><ref id="CR27"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ulasli</surname><given-names>M</given-names></name><etal/></person-group><article-title>The effects of <italic>Nigella sativa</italic> (Ns), <italic>Anthemis hyalina</italic> (Ah) and <italic>Citrus sinensis</italic> (Cs) extracts on the replication of coronavirus and the expression of TRP genes family</article-title><source>Mol Biol Rep</source><year>2014</year><volume>41</volume><issue>3</issue><fpage>1703</fpage><lpage>1711</lpage><pub-id pub-id-type="doi">10.1007/s11033-014-3019-7</pub-id><?supplied-pmid 24413991?><pub-id pub-id-type="pmid">24413991</pub-id></element-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="other">Bouchentouf S, Missoum N (2020) Identification of compounds from <italic>Nigella sativa</italic> as new potential inhibitors of 2019 novel Coronavirus (Covid-19): molecular docking study. Med Chem 28(12):35&#x02013;41</mixed-citation></ref><ref id="CR29"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ghosh</surname><given-names>R</given-names></name><etal/></person-group><article-title>Evaluation of green tea polyphenols as novel corona virus (SARS CoV-2) main protease (Mpro) inhibitors&#x02014;an in silico docking and molecular dynamics simulation study</article-title><source>J Biomol Struct Dyn</source><year>2020</year><pub-id pub-id-type="doi">10.1080/07391102.2020.1779818</pub-id><?supplied-pmid 33382027?><pub-id pub-id-type="pmid">33382027</pub-id></element-citation></ref><ref id="CR30"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sampangi-Ramaiah</surname><given-names>MH</given-names></name><name><surname>Vishwakarma</surname><given-names>R</given-names></name><name><surname>Shaanker</surname><given-names>RU</given-names></name></person-group><article-title>Molecular docking analysis of selected natural products from plants for inhibition of SARS-CoV-2 main protease</article-title><source>Curr Sci</source><year>2020</year><volume>118</volume><issue>7</issue><fpage>1087</fpage><lpage>1092</lpage></element-citation></ref><ref id="CR31"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>da Silva</surname><given-names>JKR</given-names></name><etal/></person-group><article-title>Essential oils as antiviral agents, potential of essential oils to treat SARS-CoV-2 infection: an in-silico investigation</article-title><source>Int J Mol Sci</source><year>2020</year><volume>21</volume><issue>10</issue><fpage>3426</fpage><pub-id pub-id-type="doi">10.3390/ijms21103426</pub-id><?supplied-pmid 7279430?><pub-id pub-id-type="pmid">7279430</pub-id></element-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="other">Maiti S et al (2020) Active-site molecular docking of Nigellidine to nucleocapsid/Nsp2/Nsp3/MPro of COVID-19 and to human IL1R and TNFR1/2 may stop viral-growth/cytokine-flood, and the drug source <italic>Nigella sativa</italic> (black cumin) seeds show potent antioxidant role in experimental rats. J Drug Target 27(19):245&#x02013;251&#x000a0;&#x000a0;</mixed-citation></ref><ref id="CR33"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bade</surname><given-names>BC</given-names></name><etal/></person-group><article-title>Increasing physical activity and exercise in lung cancer: reviewing safety, benefits, and application</article-title><source>J Thorac Oncol</source><year>2015</year><volume>10</volume><issue>6</issue><fpage>861</fpage><lpage>871</lpage><pub-id pub-id-type="doi">10.1097/JTO.0000000000000536</pub-id><?supplied-pmid 25831230?><pub-id pub-id-type="pmid">25831230</pub-id></element-citation></ref><ref id="CR34"><label>34.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Dowman</surname><given-names>LM</given-names></name><etal/></person-group><article-title>Effect of disease aetiology on response to exercise training in patients with interstitial lung disease</article-title><source>B16. New randomised controlled trials in pulmonary rehabilitation</source><year>2015</year><publisher-name>American Thoracic Society</publisher-name><fpage>A2460</fpage><lpage>A2460</lpage></element-citation></ref><ref id="CR35"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilt</surname><given-names>TJ</given-names></name><etal/></person-group><article-title>Management of stable chronic obstructive pulmonary disease: a systematic review for a clinical practice guideline</article-title><source>Ann Intern Med</source><year>2007</year><volume>147</volume><issue>9</issue><fpage>639</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-147-9-200711060-00009</pub-id><?supplied-pmid 17975187?><pub-id pub-id-type="pmid">17975187</pub-id></element-citation></ref><ref id="CR36"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Keyser</surname><given-names>RE</given-names></name><etal/></person-group><article-title>Changes in fatigability following intense aerobic exercise training in patients with interstitial lung disease</article-title><source>Respir Med</source><year>2015</year><volume>109</volume><issue>4</issue><fpage>517</fpage><lpage>525</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2015.01.021</pub-id><?supplied-pmid 25698651?><pub-id pub-id-type="pmid">25698651</pub-id></element-citation></ref><ref id="CR37"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casaburi</surname><given-names>R</given-names></name><etal/></person-group><article-title>Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease</article-title><source>Am Rev Respir Dis</source><year>1991</year><volume>143</volume><issue>1</issue><fpage>9</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1164/ajrccm/143.1.9</pub-id><?supplied-pmid 1986689?><pub-id pub-id-type="pmid">1986689</pub-id></element-citation></ref><ref id="CR38"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>RP</given-names></name><etal/></person-group><article-title>Aerobic exercise decreases chronic allergic lung inflammation and airway remodeling in mice</article-title><source>Am J Respir Crit Care Med</source><year>2007</year><volume>176</volume><issue>9</issue><fpage>871</fpage><lpage>877</lpage><pub-id pub-id-type="doi">10.1164/rccm.200610-1567OC</pub-id><?supplied-pmid 17690332?><pub-id pub-id-type="pmid">17690332</pub-id></element-citation></ref><ref id="CR39"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname><given-names>RP</given-names></name><etal/></person-group><article-title>Aerobic conditioning and allergic pulmonary inflammation in mice. II. Effects on lung vascular and parenchymal inflammation and remodeling</article-title><source>Am J Physiol Lung Cell Mol Physiol</source><year>2008</year><volume>295</volume><issue>4</issue><fpage>L670</fpage><lpage>L679</lpage><pub-id pub-id-type="doi">10.1152/ajplung.00465.2007</pub-id><?supplied-pmid 18757522?><pub-id pub-id-type="pmid">18757522</pub-id></element-citation></ref><ref id="CR40"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Navarro</surname><given-names>F</given-names></name><etal/></person-group><article-title>Moderate exercise increases the metabolism and immune function of lymphocytes in rats</article-title><source>Eur J Appl Physiol</source><year>2013</year><volume>113</volume><issue>5</issue><fpage>1343</fpage><lpage>1352</lpage><pub-id pub-id-type="doi">10.1007/s00421-012-2554-y</pub-id><?supplied-pmid 23212119?><pub-id pub-id-type="pmid">23212119</pub-id></element-citation></ref><ref id="CR41"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>N</given-names></name><etal/></person-group><article-title>Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study</article-title><source>Lancet</source><year>2020</year><volume>395</volume><issue>10223</issue><fpage>507</fpage><lpage>513</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(20)30211-7</pub-id><?supplied-pmid 32007143?><pub-id pub-id-type="pmid">32007143</pub-id></element-citation></ref><ref id="CR42"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abd El-Kader</surname><given-names>SM</given-names></name><name><surname>Al-Shreef</surname><given-names>FM</given-names></name></person-group><article-title>Inflammatory cytokines and immune system modulation by aerobic versus resisted exercise training for elderly</article-title><source>Afr Health Sci</source><year>2018</year><volume>18</volume><issue>1</issue><fpage>120</fpage><lpage>131</lpage><pub-id pub-id-type="doi">10.4314/ahs.v18i1.16</pub-id><?supplied-pmid 29977265?><pub-id pub-id-type="pmid">29977265</pub-id></element-citation></ref><ref id="CR43"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falkenberg</surname><given-names>R</given-names></name><name><surname>Eising</surname><given-names>C</given-names></name><name><surname>Peters</surname><given-names>M</given-names></name></person-group><article-title>Yoga and immune system functioning: a systematic review of randomized controlled trials</article-title><source>J Behav Med</source><year>2018</year><volume>41</volume><issue>4</issue><fpage>467</fpage><lpage>482</lpage><pub-id pub-id-type="doi">10.1007/s10865-018-9914-y</pub-id><?supplied-pmid 29429046?><pub-id pub-id-type="pmid">29429046</pub-id></element-citation></ref><ref id="CR44"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nieman</surname><given-names>DC</given-names></name><name><surname>Wentz</surname><given-names>LM</given-names></name></person-group><article-title>The compelling link between physical activity and the body's defense system</article-title><source>J Sport Health Sci</source><year>2019</year><volume>8</volume><issue>3</issue><fpage>201</fpage><lpage>217</lpage><pub-id pub-id-type="doi">10.1016/j.jshs.2018.09.009</pub-id><?supplied-pmid 31193280?><pub-id pub-id-type="pmid">31193280</pub-id></element-citation></ref><ref id="CR45"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>JP</given-names></name><name><surname>Turner</surname><given-names>JE</given-names></name></person-group><article-title>Debunking the myth of exercise-induced immune suppression: redefining the impact of exercise on immunological health across the lifespan</article-title><source>Front Immunol</source><year>2018</year><volume>9</volume><fpage>648</fpage><pub-id pub-id-type="doi">10.3389/fimmu.2018.00648</pub-id><?supplied-pmid 29713319?><pub-id pub-id-type="pmid">29713319</pub-id></element-citation></ref><ref id="CR46"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>JP</given-names></name><etal/></person-group><article-title>Acute exercise mobilises CD8+ T lymphocytes exhibiting an effector-memory phenotype</article-title><source>Brain Behav Immun</source><year>2009</year><volume>23</volume><issue>6</issue><fpage>767</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2009.02.011</pub-id><?supplied-pmid 19254756?><pub-id pub-id-type="pmid">19254756</pub-id></element-citation></ref><ref id="CR47"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Martin</surname><given-names>SA</given-names></name><name><surname>Pence</surname><given-names>BD</given-names></name><name><surname>Woods</surname><given-names>JA</given-names></name></person-group><article-title>Exercise and respiratory tract viral infections</article-title><source>Exerc Sport Sci Rev</source><year>2009</year><volume>37</volume><issue>4</issue><fpage>157</fpage><pub-id pub-id-type="doi">10.1097/JES.0b013e3181b7b57b</pub-id><?supplied-pmid 19955864?><pub-id pub-id-type="pmid">19955864</pub-id></element-citation></ref><ref id="CR48"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dinh</surname><given-names>HC</given-names></name><etal/></person-group><article-title>Effects of physical exercise on markers of cellular immunosenescence: a systematic review</article-title><source>Calcif Tissue Int</source><year>2017</year><volume>100</volume><issue>2</issue><fpage>193</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1007/s00223-016-0212-9</pub-id><pub-id pub-id-type="pmid">27866236</pub-id></element-citation></ref><ref id="CR49"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Campbell</surname><given-names>JP</given-names></name><etal/></person-group><article-title>The effects of vaccine timing on the efficacy of an acute eccentric exercise intervention on the immune response to an influenza vaccine in young adults</article-title><source>Brain Behav Immun</source><year>2010</year><volume>24</volume><issue>2</issue><fpage>236</fpage><lpage>242</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2009.10.001</pub-id><?supplied-pmid 19818846?><pub-id pub-id-type="pmid">19818846</pub-id></element-citation></ref><ref id="CR50"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jee</surname><given-names>Y-S</given-names></name></person-group><article-title>Exercise is an antigen for vaccination: first series of scientific evidence</article-title><source>J Exerc Rehabil</source><year>2019</year><volume>15</volume><issue>3</issue><fpage>339</fpage><pub-id pub-id-type="doi">10.12965/jer.1938302.151</pub-id><?supplied-pmid 31316923?><pub-id pub-id-type="pmid">31316923</pub-id></element-citation></ref><ref id="CR51"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>RJ</given-names></name><etal/></person-group><article-title>Can exercise affect immune function to increase susceptibility to infection?</article-title><source>Exerc Immunol Rev</source><year>2020</year><volume>26</volume><fpage>8</fpage><lpage>22</lpage><?supplied-pmid 32139352?><pub-id pub-id-type="pmid">32139352</pub-id></element-citation></ref><ref id="CR52"><label>52.</label><mixed-citation publication-type="other">Hammami A et al (2020) Physical activity and coronavirus disease 2019 (COVID-19): specific recommendations for home-based physical training. Manag Sport Leis 27(12):1&#x02013;6</mixed-citation></ref><ref id="CR53"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Senna</surname><given-names>SM</given-names></name><etal/></person-group><article-title>Moderate physical training attenuates perinatal low-protein-induced spleen lymphocyte apoptosis in endotoxemic adult offspring rats</article-title><source>Eur J Nutr</source><year>2016</year><volume>55</volume><issue>3</issue><fpage>1113</fpage><lpage>1122</lpage><pub-id pub-id-type="doi">10.1007/s00394-015-0925-y</pub-id><?supplied-pmid 25986158?><pub-id pub-id-type="pmid">25986158</pub-id></element-citation></ref><ref id="CR54"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bigley</surname><given-names>AB</given-names></name><etal/></person-group><article-title>Acute exercise preferentially redeploys NK-cells with a highly-differentiated phenotype and augments cytotoxicity against lymphoma and multiple myeloma target cells</article-title><source>Brain Behav Immun</source><year>2014</year><volume>39</volume><fpage>160</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1016/j.bbi.2013.10.030</pub-id><?supplied-pmid 24200514?><pub-id pub-id-type="pmid">24200514</pub-id></element-citation></ref><ref id="CR55"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guazzi</surname><given-names>M</given-names></name><etal/></person-group><article-title>Improvement of alveolar-capillary membrane diffusing capacity with exercise training in chronic heart failure</article-title><source>J Appl Physiol</source><year>2004</year><volume>97</volume><issue>5</issue><fpage>1866</fpage><lpage>1873</lpage><pub-id pub-id-type="doi">10.1152/japplphysiol.00365.2004</pub-id><?supplied-pmid 15220300?><pub-id pub-id-type="pmid">15220300</pub-id></element-citation></ref><ref id="CR56"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ed;a</surname><given-names>I</given-names></name><etal/></person-group><article-title>Lung capacity and alveolar gas diffusion in aquatic athletes: implications for performance and health</article-title><source>Apunts Sports Med</source><year>2021</year><volume>56</volume><issue>209</issue><fpage>100339</fpage><pub-id pub-id-type="doi">10.1016/j.apunsm.2020.100339</pub-id></element-citation></ref><ref id="CR57"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmad</surname><given-names>A</given-names></name><etal/></person-group><article-title>A review on therapeutic potential of <italic>Nigella sativa</italic>: a miracle herb</article-title><source>Asian Pac J Trop Biomed</source><year>2013</year><volume>3</volume><issue>5</issue><fpage>337</fpage><lpage>352</lpage><pub-id pub-id-type="doi">10.1016/S2221-1691(13)60075-1</pub-id><?supplied-pmid 23646296?><pub-id pub-id-type="pmid">23646296</pub-id></element-citation></ref></ref-list></back></article>